DK0840735T3 - Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl] - Google Patents

Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl]

Info

Publication number
DK0840735T3
DK0840735T3 DK96918801T DK96918801T DK0840735T3 DK 0840735 T3 DK0840735 T3 DK 0840735T3 DK 96918801 T DK96918801 T DK 96918801T DK 96918801 T DK96918801 T DK 96918801T DK 0840735 T3 DK0840735 T3 DK 0840735T3
Authority
DK
Denmark
Prior art keywords
diphenylmethyl
azabicyclo
octane
cleavage
methoxy
Prior art date
Application number
DK96918801T
Other languages
Danish (da)
English (en)
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0840735T3 publication Critical patent/DK0840735T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DK96918801T 1995-07-17 1996-07-04 Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl] DK0840735T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (1)

Publication Number Publication Date
DK0840735T3 true DK0840735T3 (da) 2004-02-09

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918801T DK0840735T3 (da) 1995-07-17 1996-07-04 Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl]

Country Status (25)

Country Link
US (1) US6008357A (cs)
EP (1) EP0840735B1 (cs)
JP (1) JP3043074B2 (cs)
KR (1) KR100276989B1 (cs)
CN (1) CN1068598C (cs)
AR (1) AR002772A1 (cs)
AT (1) ATE250600T1 (cs)
AU (1) AU697553B2 (cs)
CA (1) CA2227194C (cs)
CO (1) CO4480720A1 (cs)
CZ (1) CZ15098A3 (cs)
DE (1) DE69630123T2 (cs)
DK (1) DK0840735T3 (cs)
ES (1) ES2205039T3 (cs)
HU (1) HUP9900238A3 (cs)
IL (1) IL122655A0 (cs)
MY (1) MY115734A (cs)
NO (1) NO980211L (cs)
NZ (1) NZ310539A (cs)
PE (1) PE8798A1 (cs)
PL (1) PL184261B1 (cs)
PT (1) PT840735E (cs)
RU (1) RU2136681C1 (cs)
WO (1) WO1997003984A1 (cs)
ZA (1) ZA966026B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05003317A (es) * 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
KR100812046B1 (ko) * 2004-02-02 2008-03-10 화이자 프로덕츠 인크. 1-(2s,3s)-2-벤즈히드릴-n-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법
WO2006055321A2 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
CA2746422A1 (en) * 2008-12-09 2010-06-17 University Of Florida Research Foundation, Inc. Kinase inhibitor compounds
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
PL171921B1 (pl) * 1991-05-22 1997-06-30 Pfizer Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
UA27776C2 (uk) * 1991-05-31 2000-10-16 Пфайзер Інк. Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
RU2136681C1 (ru) 1999-09-10
WO1997003984A1 (en) 1997-02-06
JP3043074B2 (ja) 2000-05-22
JPH10511102A (ja) 1998-10-27
KR19990029058A (ko) 1999-04-15
CO4480720A1 (es) 1997-07-09
PL184261B1 (pl) 2002-09-30
DE69630123D1 (en) 2003-10-30
AU6134896A (en) 1997-02-18
CN1068598C (zh) 2001-07-18
KR100276989B1 (ko) 2001-01-15
HUP9900238A3 (en) 2001-08-28
CA2227194A1 (en) 1997-02-06
CN1190970A (zh) 1998-08-19
CZ15098A3 (cs) 1999-02-17
IL122655A0 (en) 1998-08-16
AR002772A1 (es) 1998-04-29
CA2227194C (en) 2002-02-12
HUP9900238A2 (hu) 1999-05-28
EP0840735A1 (en) 1998-05-13
ZA966026B (en) 1998-01-16
HK1010195A1 (en) 1999-06-17
ATE250600T1 (de) 2003-10-15
NO980211L (no) 1998-03-16
PE8798A1 (es) 1998-03-02
MY115734A (en) 2003-08-30
AU697553B2 (en) 1998-10-08
PT840735E (pt) 2004-02-27
MX9800538A (es) 1998-05-31
ES2205039T3 (es) 2004-05-01
PL324610A1 (en) 1998-06-08
DE69630123T2 (de) 2004-04-08
EP0840735B1 (en) 2003-09-24
US6008357A (en) 1999-12-28
NZ310539A (en) 1998-11-25
NO980211D0 (no) 1998-01-16

Similar Documents

Publication Publication Date Title
BR9611436A (pt) D-tartarato de (-)-cis-6(s)-fenil-5(r)-[4-(2-pirrolidin-1-iletóxi) fenil]-5,6,7,8,-tetra-hidronaftalen-2-ol
ID24455A (id) Alat untuk penyatuan-amorf pipa-pipa
CY2007024I2 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
FI972970A7 (fi) Uusia yhdisteitä
PT907650E (pt) N-¬4-(heteroarilmetil)fenil|heteroarilaminasc
DZ1961A1 (fr) Nouveaux composés.
FI20030162L (fi) Uusia yhdisteitä
ID20053A (id) Hipolipidemat 1,4-benzotiazepin-1,1-dioksida
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
CY2004003I2 (el) Παραγωγα 2-(2-αμινο-1, 6-διϋδρο-6-οξο-πυρινο-9-υλο)-μεθοδυ-1,3-προπανεδιολης
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
DK0754407T3 (da) Flydende formuleringer af 1,2-benzisothiazolin-3-on
TR199600137A2 (tr) Bitümlü bilesimler.
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
FI971674A0 (fi) Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina
DK0927173T3 (da) Substituerede [2-(1-piperazinyl)ethoxy]methylforbindelser
MA23779A1 (fr) Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
DK0840735T3 (da) Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl]
EP0811014A4 (en) Novel bacteriocin piscicolin 126
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
ES1031116Y (es) Barredora perfeccionada.
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.